MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Revenue
$1,973,105
Net Income
-$2,006,331
Net Profit Margin
-101.68%
EPS
-$0.28
Unit: Dollar
Revenue Breakdown
    • product gross profit
    • cost of product revenue
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Product revenue
1,973,105
1,862,050
2,892,635
4,473,792*
Cost of product revenue
790,496
871,786
1,324,807
1,861,230*
Product gross profit
1,182,609
990,264
1,567,828
2,612,562*
Collaborations revenue
-
-
-
750,000*
Selling, general and administrative
2,181,768
1,919,371
1,885,455
-275,102.5*
Research and development
1,425,153
1,468,090
1,389,680
943,640*
Total operating expenses
3,606,921
3,387,461
3,275,135
668,537.5*
Gain from operations
-2,424,312
-2,397,197
-1,707,307
2,694,024.5*
Fair value change in warrant liability
-405,702
8,271
-222,740
280,294*
Financing costs
-
-
-
306,088*
Other income
12,279
23,446
46,677
-55,804*
Gain before income taxes
-2,006,331
-2,382,022
-1,437,890
2,051,838.5
Net gain
-2,006,331
-2,382,022
-1,437,890
2,051,838.5
Basic EPS
-0.23
-0.28
-0.03
0.051
Diluted EPS
-0.28
-0.28
-0.03
0.051
Basic Average Shares
8,661,624
8,484,926
50,331,155
40,152,873*
Diluted Average Shares
8,739,505
8,484,926
50,331,155
40,152,873*
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Net gain-$2,006,331 (-33.68%↓ Y/Y)product gross profit$1,182,609 (29.27%↑ Y/Y)cost of productrevenue$790,496 (1.19%↑ Y/Y)Gain before incometaxes-$2,006,331 (-33.68%↓ Y/Y)Fair value change inwarrant liability-$405,702 (-26.93%↓ Y/Y)Other income$12,279 (-83.72%↓ Y/Y)Product revenue$1,973,105 (16.34%↑ Y/Y)Gain from operations-$2,424,312 (-28.50%↓ Y/Y)Product gross profit$1,182,609 (29.27%↑ Y/Y)Cost of productrevenue$790,496 (1.19%↑ Y/Y)Total operatingexpenses$3,606,921 (28.75%↑ Y/Y)Selling, general andadministrative$2,181,768 (34.76%↑ Y/Y)Research and development$1,425,153 (20.52%↑ Y/Y)

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)

NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)